logo

SCNX

Scienture Holdings·NASDAQ
--
--(--)
--
--(--)
9.32 / 10
Outperform

Fundamental analysis is highly favorable (score 9.3/10). Key strengths include exceptional year-over-year revenue growth (618%) and a solid interest-coverage ratio (15.5), indicating healthy earnings and low financial risk. However, inventory turnover is sluggish (1265 days), and parent-company net profit is falling (-182%), tempering the overall outlook.

Fundamental(9.32)SentimentTechnical

Analysis Checks(8/10)

Total operating revenue (YoY growth rate %)
Value618.42
Score3/3
Weight47.46%
1M Return4.49%
Quick ratio
Value0.16
Score2/3
Weight4.09%
1M Return0.56%
Total profit (YoY growth rate %)
Value-17.04
Score2/3
Weight5.52%
1M Return0.68%
Net cash flow from operating activities (YoY growth rate %)
Value27.75
Score3/3
Weight37.40%
1M Return3.96%
Fixed assets turnover ratio
Value35.84
Score3/3
Weight35.73%
1M Return4.11%
Long-term debt to working capital ratio (%)
Value27.19
Score2/3
Weight-9.09%
1M Return-1.19%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-12.97%
1M Return-1.71%
Operating revenue (YoY growth rate %)
Value618.42
Score3/3
Weight47.46%
1M Return4.49%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value-182.52
Score1/3
Weight-34.43%
1M Return-5.11%
Inventory turnover days
Value1265.70
Score1/3
Weight-21.16%
1M Return-3.18%
Is SCNX undervalued or overvalued?
  • SCNX scores 9.32/10 on fundamentals and holds a Discounted valuation at present. Backed by its -16.56% ROE, -3145.84% net margin, -0.82 P/E ratio, 0.20 P/B ratio, and -82.46% earnings growth, these metrics solidify its Outperform investment rating.